Calcium channel blocker toxicity: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
== Calcium Channel Blocker Toxicity == | |||
[[ | [[File:LipidEmulsion.JPG|thumb|right|Lipid emulsion therapy is used in the treatment of calcium channel blocker toxicity.]] | ||
'''Calcium channel blocker toxicity''' is a potentially life-threatening condition resulting from an overdose of [[calcium channel blockers]] (CCBs), a class of medications commonly used to treat [[hypertension]], [[angina]], and certain [[cardiac arrhythmias]]. | |||
== Pathophysiology == | |||
Calcium channel blockers work by inhibiting the influx of calcium ions through [[voltage-gated calcium channels]] in the [[heart]] and [[vascular smooth muscle]]. This action leads to decreased myocardial contractility, reduced heart rate, and vasodilation. In the case of an overdose, these effects are exaggerated, leading to severe [[hypotension]], [[bradycardia]], and potentially [[cardiogenic shock]]. | |||
== Clinical Presentation == | |||
Patients with calcium channel blocker toxicity may present with a variety of symptoms, including: | |||
* Severe [[hypotension]] | |||
* [[Bradycardia]] | |||
* [[Dizziness]] | |||
* [[Syncope]] | |||
* [[Confusion]] | |||
* [[Hyperglycemia]] | |||
In severe cases, patients may develop [[cardiac arrest]] or [[multi-organ failure]]. | |||
== Diagnosis == | |||
Diagnosis of calcium channel blocker toxicity is primarily clinical, based on the history of ingestion and presenting symptoms. Laboratory tests may show elevated blood glucose levels and metabolic acidosis. [[Electrocardiogram|ECG]] findings may include bradycardia and conduction delays. | |||
== Treatment == | |||
The management of calcium channel blocker toxicity involves several steps: | |||
=== Initial Stabilization === | |||
* Ensure adequate [[airway]], [[breathing]], and [[circulation]]. | |||
* Administer [[intravenous fluids]] to support blood pressure. | |||
=== Specific Therapies === | |||
* '''Calcium:''' Administer intravenous calcium (calcium chloride or calcium gluconate) to counteract the effects of calcium channel blockade. | |||
* '''Vasopressors:''' Use [[vasopressors]] such as [[norepinephrine]] to maintain blood pressure. | |||
* '''High-dose insulin therapy:''' Administer high-dose insulin and glucose to improve cardiac contractility and peripheral perfusion. | |||
* '''Lipid emulsion therapy:''' Intravenous lipid emulsion can be used as a "lipid sink" to sequester lipophilic drugs, as shown in the image. | |||
== Prognosis == | |||
The prognosis of calcium channel blocker toxicity depends on the amount ingested, the time to treatment, and the specific agent involved. Early recognition and aggressive treatment improve outcomes. | |||
== Related Pages == | |||
* [[Calcium channel blocker]] | |||
* [[Cardiac arrhythmia]] | |||
* [[Hypertension]] | |||
* [[Lipid emulsion therapy]] | |||
{{Toxicology}} | |||
{{Cardiology}} | |||
[[Category:Toxicology]] | [[Category:Toxicology]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
Revision as of 16:29, 16 February 2025
Calcium Channel Blocker Toxicity
Calcium channel blocker toxicity is a potentially life-threatening condition resulting from an overdose of calcium channel blockers (CCBs), a class of medications commonly used to treat hypertension, angina, and certain cardiac arrhythmias.
Pathophysiology
Calcium channel blockers work by inhibiting the influx of calcium ions through voltage-gated calcium channels in the heart and vascular smooth muscle. This action leads to decreased myocardial contractility, reduced heart rate, and vasodilation. In the case of an overdose, these effects are exaggerated, leading to severe hypotension, bradycardia, and potentially cardiogenic shock.
Clinical Presentation
Patients with calcium channel blocker toxicity may present with a variety of symptoms, including:
In severe cases, patients may develop cardiac arrest or multi-organ failure.
Diagnosis
Diagnosis of calcium channel blocker toxicity is primarily clinical, based on the history of ingestion and presenting symptoms. Laboratory tests may show elevated blood glucose levels and metabolic acidosis. ECG findings may include bradycardia and conduction delays.
Treatment
The management of calcium channel blocker toxicity involves several steps:
Initial Stabilization
- Ensure adequate airway, breathing, and circulation.
- Administer intravenous fluids to support blood pressure.
Specific Therapies
- Calcium: Administer intravenous calcium (calcium chloride or calcium gluconate) to counteract the effects of calcium channel blockade.
- Vasopressors: Use vasopressors such as norepinephrine to maintain blood pressure.
- High-dose insulin therapy: Administer high-dose insulin and glucose to improve cardiac contractility and peripheral perfusion.
- Lipid emulsion therapy: Intravenous lipid emulsion can be used as a "lipid sink" to sequester lipophilic drugs, as shown in the image.
Prognosis
The prognosis of calcium channel blocker toxicity depends on the amount ingested, the time to treatment, and the specific agent involved. Early recognition and aggressive treatment improve outcomes.
Related Pages
| Toxicology | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Cardiovascular disease A-Z
Most common cardiac diseases
- Cardiac arrhythmia
- Cardiogenetic disorders
- Cardiomegaly
- Cardiomyopathy
- Cardiopulmonary resuscitation
- Chronic rheumatic heart diseases
- Congenital heart defects
- Heart neoplasia
- Ischemic heart diseases
- Pericardial disorders
- Syndromes affecting the heart
- Valvular heart disease
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
A
- Accelerated idioventricular rhythm
- Acute decompensated heart failure
- Arteriosclerotic heart disease
- Athletic heart syndrome
- Atrial flutter
- Atrioventricular fistula
- Cardiovascular disease in Australia
- Autoimmune heart disease
B
C
- Ebb Cade
- Cardiac allograft vasculopathy
- Cardiac amyloidosis
- Cardiac asthma
- Cardiac tamponade
- Cardiogenic shock
- Cardiogeriatrics
- Cardiorenal syndrome
- Cardiotoxicity
- Carditis
- Coronary artery aneurysm
- Coronary artery anomaly
- Coronary artery disease
- Spontaneous coronary artery dissection
- Coronary artery ectasia
- Coronary occlusion
- Coronary steal
- Coronary thrombosis
- Coronary vasospasm
- Cœur en sabot
- Coxsackievirus-induced cardiomyopathy
D
E
H
- Heart attack
- Heart failure
- Heart failure with preserved ejection fraction
- Heart to Heart (1949 film)
- High-output heart failure
- Hyperdynamic precordium
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
I
- Idiopathic giant-cell myocarditis
- Interventricular dyssynchrony
- Intraventricular dyssynchrony
- Isolated atrial amyloidosis
K
L
M
- Mydicar
- Myocardial bridge
- Myocardial disarray
- Myocardial rupture
- Myocardial scarring
- Myocardial stunning
- Myocarditis
N
O
P
- Papillary fibroelastoma
- Pathophysiology of heart failure
- Postpericardiotomy syndrome
- Pulmonary vein stenosis
R
S
- Saturated fat and cardiovascular disease
- SCAR-Fc
- Shone's syndrome
- Strain pattern
- Subacute bacterial endocarditis
- Sudden cardiac death of athletes
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z